PASTA
Live / Applied — Fifth extension granted (statement of use) (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 23 Aug 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90896969
- Mark type
- Stylized text
- Filed
- 23 Aug 2021
- Published for opposition
- 10 Jan 2023
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for human use, namely, pharmaceutical preparations administered via parenteral injection or infusion for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
Prosecution history
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 5 GRANTED
- 19 Aug 2025 — SOU EXTENSION 5 FILED
- 07 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2025 — SOU EXTENSION 4 GRANTED
- 04 Mar 2025 — SOU EXTENSION 4 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2024 — SOU EXTENSION 3 GRANTED
- 05 Sept 2024 — SOU EXTENSION 3 FILED
- 05 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2024 — SOU EXTENSION 2 GRANTED